Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …

The current achievements in treating glioblastoma (GBM) patients are not sufficient because
many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem …

Integrating multifunctionality such as adhesiveness, stretchability, and self-healing ability on
a single hydrogel has been a challenge and is a highly desired development for various …

Due to their good absorption, satisfactory biocompatibility, and high safety, hydrogels have
been widely used in the field of biomedicine, including for drug delivery and tissue …

Vat photopolymerization is an additive manufacturing process that produces high-
performance ceramic parts. A critical step in the process is the preparation of a suspension …

The complexity of hard‐to‐treat diseases strongly undermines the therapeutic potential of
available treatment options. Therefore, a paradigm shift from monotherapy toward …

For breast cancer patients who have undergone breast‐conserving surgery, effective
treatments to prevent local recurrences and metastases is very essential. Here, a local …

The delivery of therapeutics to the brain in an efficient, noninvasive manner continues to be
a major unmet need in the field of drug delivery. One significant impediment to brain delivery …

The central nervous system (CNS), consisting of the brain, spinal cord, and retina,
superintends to the acquisition, integration and processing of peripheral information to …

Glioblastoma multiforme (GBM) is a fatal central nervous system tumor without effective
treatment. Chemotherapeutic agents are mainstays in the treatment of glioblastoma …